Provided by Tiger Trade Technology Pte. Ltd.

Trinity Biotech PLC

0.6050
+0.00500.83%
Volume:17.99K
Turnover:10.95K
Market Cap:11.32M
PE:-0.41
High:0.6275
Open:0.6000
Low:0.6000
Close:0.6000
52wk High:3.44
52wk Low:0.5012
Shares:18.71M
Float Shares:14.88M
Volume Ratio:0.65
T/O Rate:0.12%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4937
EPS(LYR):-1.8319
ROE:-1913.45%
ROA:-9.46%
PB:-0.21
PE(LYR):-0.33

Loading ...

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading

MT Newswires Live
·
Apr 24

European Equities Traded in US as ADRs Ease in Thursday Trading

MT Newswires Live
·
Apr 23

European Equities Traded in the US as American Depositary Receipts Sharply Higher in Friday Trading

MT Newswires Live
·
Apr 17

European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading

MT Newswires Live
·
Apr 15

European Equities Traded in the US as ADRs Rise in Tuesday Trading

MT Newswires Live
·
Apr 14

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

MT Newswires Live
·
Apr 13

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 09

Trinity Biotech director Ronan O’Caoimh files initial beneficial ownership statement

Reuters
·
Apr 09

European Equities Traded in the US as American Depositary Receipts Track Lower in Tuesday Trading

MT Newswires Live
·
Apr 07

Trinity Biotech interim CFO Paul Murphy files initial beneficial ownership statement

Reuters
·
Apr 03

Trinity Biotech director Andrew Omidvar files initial beneficial ownership statement

Reuters
·
Apr 03

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Apr 02

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
Mar 31

European Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
Mar 26

Trinity Biotech reports 85% AUC in 750-sample study of enhanced EpiCapture prostate cancer test; commercialization plans advance via New York reference laboratory

Reuters
·
Mar 25

BUZZ-Trinity Biotech rises as prostate cancer test shows strong accuracy

Reuters
·
Mar 23

Trinity Biotech Plc - Plans to Commercialize Epicapture Test Through New York Reference Laboratory

THOMSON REUTERS
·
Mar 23

Trinity Biotech Plc - New Epicapture Test Delivers Clinical Accuracy (Auc) of 85% in Latest Study

THOMSON REUTERS
·
Mar 23

Trinity Biotech Announces Successful Clinical Results for Its Enhanced Epicapture™ Prostate Cancer Test

THOMSON REUTERS
·
Mar 23

European Equities Traded in the US as American Depositary Receipts Fall Sharply in Thursday Trading

MT Newswires Live
·
Mar 19